Synthesis and determination of acute and chronic pain activities of 1-[1-(4-methylphenyl)(cyclohexyl)] morpholine as a new phencyclidine derivative in rats

Abbas Ahmadi; Mohsen Khalili; Ramin Hajikhani; Moslem Naserbakht

doi:10.1055/s-0031-1296173

Arzneimittelforschung, Inhaltsverzeichnis

Arzneimittelforschung 2011; 61(2): 92-97
DOI: 10.1055/s-0031-1296173

Analgesics · Anti-inflammatories · Antiphlogistics · Antirheumatic Drugs

Editio Cantor Verlag Aulendorf (Germany)

Synthesis and determination of acute and chronic pain activities of 1-[1-(4-methylphenyl)(cyclohexyl)] morpholine as a new phencyclidine derivative in rats

Authors

Abbas Ahmadi

¹Department of Chemistry, Faculty of Science, Islamic Azad University, Karaj branch, Karaj, Iran
Mohsen Khalili

²Department of Physiology, Neuroscience and Herbal Medicine Research Centers, Shahed University, Tehran, Iran
Ramin Hajikhani

³Department of Physiology, Faculty of Science, Islamic Azad University, Karaj branch, Karaj, Iran
Moslem Naserbakht

¹Department of Chemistry, Faculty of Science, Islamic Azad University, Karaj branch, Karaj, Iran

Abstract

Phencyclidine (1-(1-phenylcyclohexyl)piperidine, CAS 77-10-1, PCP, I) and many of its analogues have been synthesized and their pharmacological properties studied. In this research, new methyl morpholine derivative of phencyclidine (1-[1-(4-methylphenyl)(cyclohexyl)] morpholine, Methyl-PCM, III) was synthesized and the acute and chronic pain activities were studied using tail immersion and formalin tests on rats and compared to PCP and PCM (1-(1-phenylcyclohexyl)-morpholine, CAS 2201-40-3, PCP-mor-pholine, II).

The results indicated that Methyl-PCM (III, 6 mg/kg, i.p) produces more analgesic effects in tail immersion test (as a model of acute thermal pain) in comparison with the PCP, PCM and control groups. Meanwhile, this analgesic effect was markedly shown 5-15 min after the compound III application. In formalin test analysis, the acute pain (phase I) could not be affected by any drugs, but the chronic formalin pain (phase II) could be diminished by PCM and especially compound III. The chronic analgesic effect of Methyl-PCM was markedly shown in the late phase of chronic pain.

Key words

Acute and chronic pain - CAS 77-10-1 - CAS 2201-40-3 - Methyl morpholine derivative of phencyclidine - Tail immersion and formalin tests

Volltext

Referenzen

References
1 Ahmadi A, Mahmoudi A. Synthesis with improved yield and study on analgesic effect of 2-methoxyphencyclidine. Arzneimittelforschung. 2006; 56 () 346-50
2 Al-deeb OAA. Synthesis and analgesic activity of new phencyclidine derivatives. Arzneimittelforschung. 1994; 44 (10) 1141-4
3 Mori A, Noda Y, Mamiya T, Miyamoto Y, Nakajima A, Furukawa H et al Phencyclidine-induced discriminative stimulus is mediated via phencyclidine binding sites on the N-methyl-D-aspartate receptor-ion channel complex, not via sigma receptors. Behav Brain Res. 2001; 119: 33-40
4 Ahmadi A, Mahmoudi A. Synthesis and biological properties of 2-hydroxy-1-(1-phenyltetralin) piperidine and some of its intermediates as derivatives of phencyclidine. Arzneimittelforschung. 2005; 55 (9) 528-32
5 Al-deeb OAA. New analgesics derived from the phencyclidine analogue thiencyclidine. Arzneimittelforschung. 1996; 46 (5) 505-8
6 Ogunbadeniyi AM, Adejare A. Syntheses of fluorinated phencyclidine analogs. J Fluorine Chem. 2002; 114: 39-42
7 Ahmadi A, Shafiezadeh M, Fathollahi Y, Darvich MR, Mahmoudi A, Bahmani M et al Synthesis with improved yield and study on analgesic effect of 2-hydroxyphencyclidine. Arzneimittelforschung. 2005; 55 (3) 172-6
8 Kamenka IM, Ung MSN, Herrmann P. Determination con-formationnelle de derives de la phencyclidine en vue d’une correlation acture-active. Eur J Med Chem Ther. 1979; 14 (IV) 301-8
9 Kamenka IM, Chiche B, Goudal R, Geneste P, Vignon I, Vincent IP et al Chemical synthesis and molecular pharmacology of hydroxylated 1-(1-phenylcyclohexyl) piperidine derivatives. J Med Chem. 1982; 25: 431-5
10 Itzhak Y, Kalir A, Weissman BA, Cohen S. New analgesic drugs derived from phencyclidine. J Med Chem. 1981; 24: 496-9
11 Ahmadi A, Khalili M, Abbassi S, Javadi M, Mahmoudi A, Hajikhani R. Synthesis and Study on Analgesic Effects of 1-[1-[4-methylphenyl][cyclohexyl]-4-piperidinol and 1-[1-[4-methoxyphenyl][cyclohexyl]]-4-piperidinol as two new phencyclidine derivatives. Arzneimittelforschung. 2009; 59 (4) 202-6
12 Ahmadi A, Khalili M, Mihandoust F, Barghi L. Synthesis and determination of acute and chronic pain activities of 1-[1-(3-methyphenyl)(tetralyl)]piperidine as a new derivative of phencyclidine via tail immersion and formalin tests. Arzneimittelforschung. 2010; 60 (1) 30-5
13 Ahmadi A, Solati I, Hajikhani R, Onagh M, Javadi M. Synthesis and analgesic effects of 1-[1-(2-methylphenyl)(cyclo-hexyl)]-3-piperidinol as a new derivative of phencyclidine in mice. Arzneimittelforschung. 2010; 60 (8) 492-6
14 Johnson PY, Pan R, Quan Wen I, Halfman CJ. Synthesis of amine derivatives of phencyclidine. J Org Chem. 191; 46: 2049-54
15 Chen DM, Chen K, Wang H. Antithrombotic effects of morpholine and piperazine ring derivatives and their molecular mechanism. Yao Xue Xue Bao. 2003; 38 (9) 641-5
16 Regnier G, Guillonneau C, Lepagnol I, Lestage P. Assignee: Adir et compagnie, Courbevoie, France; Morpholine compounds, compositions and use. United States Patent. 1991; 5026701
17 Kaneyoshi K, Takayuki D, Mitsuo Y. Assignee: Takeda Chemical Industries LTD., Japan; Tetracyclic morpholine derivatives and their use as analgesics. European Patent. 1994; 0610793
18 Rekka E, Retsas S, Demopoulos VJ, Kourounakis PN. Lipophilicity of some substituted morpholine derivatives synthesized as potential antinociceptive agents. Arch Pharm (Weinheim). 1990; 323 (1) 53-6
19 Soine WH. Clandestine drug synthesis. Med Res Rev. 1986; 6 (1) 41-74
20 Budd RD. Phencyclidine (PCP)-structure versus reactivity. Clin Toxicol. 1981; 18 (9) 1033-41
21 Geneste P, Kamenka JM, Dessapt P. Method for stereoselective production of substituted cyclohexylcyanhydrines. Bull Soc Chim Fr. 1980; II: 187-91
22 Abdol-Rahman MO, Aboul-Eneim MN, Tammom GH. Action of Grignard reagents aryl lithium on 1,1-disubstituted cyclohexane derivatives. Egypt J Chem. 1975; 18 (3) 581-6
23 Maddox VH, Godefroi EF, Parcell RF. The synthesis of phencyclidine and other 1-arylcyclohexylamines. J Med Chem. 1965; 8: 230-5
24 Ramabadran K, Bansinath M, Turndorf H, Puig MM. Tail immersion test for the evaluation of a nociceptive reaction in mice: methodological considerations. J Pharmacol Methods. 1989; 21 (1) 21-31
25 Molina N, Bedran-de-Castro MT, Bedran-de-Castro JC. Sex-related differences in the analgesic response to the rat tail immersion test. Braz J Med Biol Res. 1994; 27 (7) 1669-72
26 Hamura H, Yoshida M, Shimizu K, Matsukura T, Suzuki H, Narita M et al Antinociceptive effect of the combination of pentazocine with morphine in the tail-immersion and scald-pain tests in rats. Jpn J Pharmacol. 2000; 83 (4) 286-92
27 Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 1977; 4 (2) 161-74
28 Mozayani A. Phencyclidine-effects on human performance and behavior. Forensic Sci Rev. 2003; 15 (1) 62-74
29 Dougherty PM, Staats PS. Intrathecal drug therapy for chronic pain from basic science to clinical practice. Anesthesiology. 1999; 91: 189-918
30 Proksch JW, Gentry WB, Owens SM. The effect of rate of drug administration on the extent and time course of phencyclidine distribution in rat brain, testis, and serum. Drug Metab Dispos. 2000; 28 (7) 742-7
31 Deleuze-Masquefa C, Michaud M, Vignon J, Kamenka JM. 1-[1–2-Benzo[b]thiopheneyl)cyclohexyl]piperidine hydrochloride (BTCP) yields two active primary metabolites in vitro: synthesis, identification from rat liver microsome extracts, and affinity for the neuronal dopamine transporter. J Med Chem. 1997; 40 (25) 4019-25